Backing UK Innovation with the £100M CIC Opportunity Fund 🚀 We’re pleased to launch the CIC Opportunity Fund, a £100 million growth fund anchored by @avivainvestors and @BPatientCap, with cornerstone commitments of £15 million and £20 million, respectively. This fund is designed to provide crucial scale-up financing for the UK’s deep tech and life sciences companies - helping them navigate the critical next stage of growth and remain competitive on a global stage. The UK is home to world-class research and breakthrough innovation, but too often, companies struggle to secure the funding needed to scale. With investments of up to £20 million per company, we aim to bridge this gap, ensuring that more IP-rich, high-impact businesses can grow and thrive in the UK. This investment also reflects the strong commitment of Aviva Investors and British Patient Capital to the UK’s innovation ecosystem. Their support strengthens Cambridge’s position as a world-leading science and technology hub and aligns with broader efforts to develop the Oxford-Cambridge Growth Corridor. We’re excited to partner with investors who share our vision and look forward to supporting the next generation of globally competitive technology companies. #CICOpportunityFund #VentureCapital #DeepTech #LifeSciences #Innovation #ScaleUp #Cambridge

"Very happy to share that @MECCambridge is announcing a new scholarship for women studying data intensive science! This provides a full scholarship to Cambridge's MPhil in Data Intensive Science for eligible students. Please share with your networks!" murrayedwards.cam.ac.uk/coll…

Join us for a special event on 29th Nov @CambridgeJBS to envision the future of #healthcare. Places are limited. Email envision@jbs.cam.ac.uk for more information asap. #HealthcareInnovation @CamPostdocs @MedCambridge @CamBiochem @CamBioCampus @Cambridge_Uni

Mentor Highlight: Miranda Weston-Smith The impulse programme wouldn't be what it is without the amazing contribution our mentors make. Thank you for being part of impulse since the beginning @BioBeatUK #IECambridge #entrepreneurship #innovation #mentor

Following this year's #BioBeat23 conference, we are delighted to host a follow-up workshop which aims to help businesses gain a better understanding of the role IP plays in getting investment or deal ready. 8.30 AM, 16 June 2023, Clayton Hotel Cambridge info.appleyardlees.co.uk/inv…

Appleyard Lees is proud to sponsor #BioBeat23. Cambridge-based patent attorneys Barbara Fleck, Appleyard Lees partner, and Claire Devine, Appleyard Lees associate, will attend.

'I’m curious to know, how did you get into biotech investing?' was a great place for Miranda Weston-Smith to start the conversation with @molotova_a which forms the basis of the guest blog on the One Nucleus website ahead of BioBeat23…lnkd.in/ei6MQhNC

We are thrilled to announce that we have raised £37.5 million in an oversubscribed Series A financing. The funds will be used to advance our autoimmune disease programmes, fuel expansion of our dark genome atlas and further develop our pioneering platform. nucleome.com/news-publicatio…